Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-01-26
2009-12-15
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S199000
Reexamination Certificate
active
07632849
ABSTRACT:
An indazolamide (I), wherein X, R1, R2, R3, R4, R5, R6, R7 and R8 have the meanings given in the description, and addition salts thereof with a pharmaceutically acceptable acid, a method for the preparation thereof and a pharmaceutical composition containing the same.
REFERENCES:
patent: 3705175 (1972-12-01), Magdanyi et al.
patent: 5654320 (1997-08-01), Catlow et al.
patent: 6096476 (2000-08-01), Yanagida et al.
patent: 6096746 (2000-08-01), Suzuki et al.
patent: 6770650 (2004-08-01), Gong et al.
patent: 0 732 333 (1996-09-01), None
patent: 0 908 459 (1999-04-01), None
patent: 0 975 623 (2000-02-01), None
patent: 98/07728 (1998-02-01), None
Takatani et al. “Fused inmidazopyridine . . . ” CA 128:3692 (1997).
Schaus et al. “Synthesis and structure-activity relationships . . . ” J. Med. chem. v.41, p. 1943-1955 (1998).
Englen et al. “Central 5HT4 receptors” Trends in pharmacol. sci. v.16(1111) p. 391-398 (1995).
U.S. Appl. No. 10/564,854, filed Jan. 17, 2006, Guglielmotti, et al.
Ashburn, Michael A.: “Management of chronic pain”, The Lancet, vol. 353, pp. 1865-1869, May 29, 1999.
Wall, Patrick D.; Melzack, Ronald Eds.: Textbook of Pain, Fourth Edition, Churchill Livingstone, 1999.
Scholz, Joachim; Woolf, Clifford J.: “Can we conquer pain?”, Nature Neuroscience Supplement, vol. 5, pp. 1062-1067, Nov. 2002.
Prugh, John D.: “A Simple Method of Protecting A Secondary Amine with tert Butyloxycarbonyl (BOC) in the Presence of A Primary Amine”, Synthetic Communications, vol. 22, No. 16, pp. 2357-2360, 1992.
Corsi, Giorgio: “1-Halobenzyl-1H-indazole-3-carboxylic acids. A New Class of Antispermatogenic Agents”, Journal of Medicinal Chemistry, vol. 19, No. 6, pp. 778-783, 1976, (1975).
Larock, Richard C.: “Comprehensive Organic Transformations”, VCH, pp. 965-966, (2000).
J.O.C., vol. 23, p. 621, Apr. 1958.
Trivedi, J.P.: “Potential Local Anaesthetics: Synthesis of Benzyloxy-Acetanilides and Propionanilides”, Indian J. Appl. Chem., vol. 30, Nos. 3-4, pp. 91-95, 1967.
Buu-Hoi, N. P.: “Indazole-3-carboxylic Acids and their Derivatives”, Institut de Chimie des Substances Naturelles du C.N.R.S., J. Heterocyclic Chem., vol. 1, No. 5, pp. 239-241, Dec. 1964.
Randall, Lowell O.: “A Method for Measurement of Analgesic Activity on Inflamed Tissue”, Arch. Int. Pharmacodyn. Ther., vol. 111, pp. 409-419, 1957.
Andrew, David: “Mechanical and Heat Sensitization of Cutaneous Nociceptors After Peripheral Inflammation in The Rat”, J. Neurophysiol., vol. 82, No. 5, pp. 2649-2656, 1999.
Hargreaves, K.: “A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia”, Pain, vol. 32, pp. 77-88, 1988.
Courteix, C.: Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain, Pain, vol. 53, pp. 81-88, 1993.
Bannon, A. W.: “ABT-594, a novel cholinergic channel modulator, is efficacious in nerve ligation and diabetic neuropathy models of neuropathic pain”, Brain Research, vol. 801, pp. 158-163, 1998.
Alisi Maria Alessandra
Cazzolla Nicola
Furlotti Guido
Guglielmotti Angelo
Luna Giuseppe
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A.
Chang Celia
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
LandOfFree
Indazolamides with analgesic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indazolamides with analgesic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indazolamides with analgesic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4059189